Yunhe Liu

Yunhe Liu

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2023 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
YCYanshuo Chu
Yanshuo Chu
EDEnyu Dai
Enyu Dai
YLYating Li
Yating Li
GHGuangchun Han
Guangchun Han
GPGuangsheng Pei
Guangsheng Pei
LWLinghua Wang
Linghua Wang

21 August 2024 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
PDF file
GGGunsagar S. Gulati
Gunsagar S. Gulati
JDJeremy Philip D’sIlva
Jeremy Philip D’sIlva
YLYunhe Liu
Yunhe Liu
LWLinghua Wang
Linghua Wang
ANAaron M. Newman
Aaron M. Newman

28 February 2024 in Nature
Verified
Journal Article
Open access
PDF file
GHGuangchun Han
Guangchun Han
ASAnsam Sinjab
Ansam Sinjab
ZRZahraa Rahal
Zahraa Rahal
ALAnne M. Lynch
Anne M. Lynch
WTWarapen Treekitkarnmongkol
Warapen Treekitkarnmongkol
HKHumam Kadara
Humam Kadara
Understanding the cellular processes that underlie early lung adenocarcinoma (LUAD) development is needed to devise intervention strategies1. Here we studied 246,102 single epithelial cells from 16 early-stage LUADs and 47 matched normal lung samples. Epithelial cells comprised diverse normal and cancer cell states, and diversity among cancer cells was strongly linked to LUAD-specific oncogenic drivers. KRAS mutant cancer cells showed distinct transcriptional features, reduced differentiation and low levels of aneuploidy. Non-malignant areas surrounding human LUAD samples were enriched with alveolar intermediate cells that displayed elevated KRT8 expression (termed KRT8+ alveolar intermediate cells (KACs) here), reduced differentiation, increased plasticity and driver KRAS mutations. Expression profiles of KACs were enriched in lung precancer cells and in LUAD cells and signified poor survival. In mice exposed to tobacco carcinogen, KACs emerged before lung tumours and persisted for months after cessation of carcinogen exposure. Moreover, they acquired Kras mutations and conveyed sensitivity to targeted KRAS inhibition in KAC-enriched organoids derived from alveolar type 2 (AT2) cells. Last, lineage-labelling of AT2 cells or KRT8+ cells following carcinogen exposure showed that KACs are possible intermediates in AT2-to-tumour cell transformation. This study provides new insights into epithelial cell states at the root of LUAD development, and such states could harbour potential targets for prevention or intervention.

23 April 2025 in Nature
Verified
Journal Article
Closed access
PDF file
GPGuangsheng Pei
Guangsheng Pei
JMJimin Min
Jimin Min
KRKimal I. Rajapakshe
Kimal I. Rajapakshe
VBVittorio Branchi
Vittorio Branchi
YLYunhe Liu
Yunhe Liu
AMAnirban Maitra
Anirban Maitra

25 August 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
JJJiahui Jiang
Jiahui Jiang
YLYunhe Liu
Yunhe Liu
JQJiangjiang Qin
Jiangjiang Qin
JCJianfeng Chen
Jianfeng Chen
JWJingjing Wu
Jingjing Wu
LWLinghua Wang
Linghua Wang
Recent advances in spatial transcriptomics (ST) techniques provide valuable insights into cellular interactions within the tumor microenvironment (TME). However, most analytical tools lack consideration of histological features and rely on matched single-cell RNA sequencing data, limiting their effectiveness in TME studies. To address this, we introduce the Morphology-Enhanced Spatial Transcriptome Analysis Integrator (METI), an end-to-end framework that maps cancer cells and TME components, stratifies cell types and states, and analyzes cell co-localization. By integrating spatial transcriptomics, cell morphology, and curated gene signatures, METI enhances our understanding of the molecular landscape and cellular interactions within the tissue. We evaluate the performance of METI on ST data generated from various tumor tissues, including gastric, lung, and bladder cancers, as well as premalignant tissues. We also conduct a quantitative comparison of METI with existing clustering and cell deconvolution tools, demonstrating METI’s robust and consistent performance.

25 July 2024 in Briefings in Bioinformatics
Verified
Journal Article
Open access
PDF file
QFQiqing Fu
Qiqing Fu
CDChenyu Dong
Chenyu Dong
YLYunhe Liu
Yunhe Liu
XXXiaoqiong Xia
Xiaoqiong Xia
GLGang Liu
Gang Liu
LLLei Liu
Lei Liu
Cell-type annotation is a critical step in single-cell data analysis. With the development of numerous cell annotation methods, it is necessary to evaluate these methods to help researchers use them effectively. Reference datasets are essential for evaluation, but currently, the cell labels of reference datasets mainly come from computational methods, which may have computational biases and may not reflect the actual cell-type outcomes. This study first constructed an experimentally labeled immune cell-subtype single-cell dataset of the same batch and systematically evaluated 18 cell annotation methods. We assessed those methods under five scenarios, including intra-dataset validation, immune cell-subtype validation, unsupervised clustering, inter-dataset annotation, and unknown cell-type prediction. Accuracy and ARI were evaluation metrics. The results showed that SVM, scBERT, and scDeepSort were the best-performing supervised methods. Seurat was the best-performing unsupervised clustering method, but it couldn't fully fit the actual cell-type distribution. Our results indicated that experimentally labeled immune cell-subtype datasets revealed the deficiencies of unsupervised clustering methods and provided new dataset support for supervised methods.